Brazil Women’s Health Market Size & Outlook, 2023-2030
Brazil women’s health market, 2018-2030 (US$M)
Related Markets
Brazil women’s health market highlights
- The Brazil women’s health market generated a revenue of USD 808.4 million in 2023 and is expected to reach USD 1,268.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 808.4 million |
| Market revenue in 2030 | USD 1,268.7 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.8% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil women’s health market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 863.6 million by 2030.
Contraceptives was the largest segment with a revenue share of 43.48% in 2023. Horizon Databook has segmented the Brazil women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has a significant population of young women with diverse economic backgrounds. The growing middle-class population, along with increasing disposable income and enhanced lifestyle, is a major factor contributing to the growth of the market.
Such factors are expected to increase the prevalence of target diseases in the country. For instance, according to an article published by the North American Menopause Society in December 2023, the prevalence of moderate to severe vasomotor symptoms (VMS) in postmenopausal Brazilian women was 36.2%.
Brazil has been witnessing positive economic growth due to the region's recent financial and political stability. The pharmaceutical industry has shown greater improvements than other industries in the country, owing to increasing government investments to enhance healthcare infrastructure.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil women’s health market size, by application, 2018-2030 (US$M)
Brazil Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
